AstraZeneca PLC (AZN) shareholders
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 117,761,076 | 7.60% | 13G (passive) amendment | Mar 31, 2025 |
| Vanguard Capital Management | 77,965,099 | 5.02% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of AZN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Investor Ab | 51,587,810 | 3.33% | $9.78B | – | 67.92% |
| Vanguard Capital Management LLC | 45,386,190 | 2.93% | $8.47B | +346,048 | 0.18% |
| Capital International Investors | 34,576,070 | 2.23% | $6.49B | +183,057 | 1.34% |
| Norges Bank | 33,864,172 | 2.18% | $6.33B | New | 0.63% |
| Capital World Investors | 30,075,134 | 1.94% | $5.63B | +1,810,554 | 0.66% |
| FMR LLC | 28,895,264 | 1.86% | $5.42B | −706,460 | 0.24% |
| Wellington Management Group Llp | 28,537,243 | 1.84% | $5.36B | +4,786,158 | 0.92% |
| Legal & General Group Plc | 25,750,245 | 1.66% | $4.82B | −99,733 | 1.00% |
| JPMorgan Chase & Co | 19,204,823 | 1.24% | $3.67B | +613,901 | 0.20% |
| VANGUARD ASSET MANAGEMENT, Ltd | 18,712,920 | 1.21% | $3.49B | +177,605 | 2.36% |
| Primecap Management Co/Ca/ | 18,095,178 | 1.17% | $3.43B | −118,530 | 2.03% |
| Bank Of America Corp /De/ | 17,690,462 | 1.14% | $3.35B | −1,367,865 | 0.22% |
| Price T Rowe Associates Inc /Md/ | 16,616,629 | 1.07% | $3.15B | −2,872,591 | 0.32% |
| Franklin Resources Inc | 16,511,727 | 1.06% | $3.11B | −1,280,434 | 0.67% |
| Amundi | 16,422,784 | 1.06% | $3.11B | +1,036,635 | 0.75% |
| Vanguard Fiduciary Trust Co | 13,291,085 | 0.86% | $2.48B | +95,907 | 0.55% |
| Deutsche Bank AG\ | 12,640,672 | 0.82% | $2.40B | +510,948 | 0.70% |
| Jupiter Topco LLC | 11,866,013 | 0.77% | $2.22B | New | 0.91% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 11,720,479 | 0.76% | $2.19B | −1,218,125 | 1.68% |
| Fisher Asset Management, LLC | 11,146,292 | 0.72% | $2.11B | +300,584 | 0.63% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1,472 | 808M | 52.1% | 280 / 517 | 475 / 108 | 95M | 29M |
| Q1 2026 | 1,328 | 756M | 48.8% | 1278 / 22 | 25 / 3 | 756M | 0M |
| Q4 2025 | 54 | 1M | 0.0% | 49 / 2 | 1 / 2 | 1M | 0M |
| Q3 2025 | 7 | 0M | 0.0% | 2 / 4 | 0 / 0 | 0M | 0M |
| Q2 2025 | 5 | 0M | 0.0% | 1 / 1 | 2 / 0 | 0M | 0M |
| Q1 2025 | 4 | 0M | 0.0% | 1 / 0 | 2 / 0 | 0M | 0M |
| Q4 2024 | 3 | 0M | 0.0% | 0 / 1 | 1 / 1 | 0M | 0M |
| Q3 2024 | 4 | 0M | 0.0% | 1 / 0 | 1 / 1 | 0M | 0M |
| Q2 2024 | 4 | 0M | 0.0% | 1 / 1 | 1 / 0 | 0M | 0M |
| Q1 2024 | 4 | 0M | 0.0% | 1 / 0 | 2 / 0 | 0M | 0M |
| Q4 2023 | 3 | 0M | 0.0% | 1 / 0 | 1 / 0 | 0M | 0M |
| Q3 2023 | 2 | 0M | 0.0% | 0 / 1 | 1 / 1 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Mani Sharma | See remarks | 19,292 | 0.00% | Nov 10, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Mani Sharma See remarks | Nov 6, 2026 | Award | +1 | $186.24 | $186 | 19,292 |
| Mani Sharma See remarks | Oct 6, 2026 | Award | +2 | $159.80 | $320 | 19,291 |
| Mani Sharma See Remarks | Sep 8, 2026 | Award | +1 | $162.60 | $163 | 19,289 |
| Mani Sharma See Remarks | Aug 8, 2026 | Buy | +20.23 | $160.57 | $3.25K | 19,288 |
| Mani Sharma SVP, Group Controller | Aug 6, 2026 | Award | +2 | $163.34 | $327 | 19,267 |
| Mani Sharma See Remarks | Jul 6, 2026 | Award | +2 | $190.43 | $381 | 19,265 |
| Mani Sharma See Remarks | Jun 8, 2026 | Award | +1 | $179.75 | $180 | 19,263 |
| Mani Sharma See Remarks | May 20, 2026 | Sale | −11,893 | $185.78 | $2.21M | 19,262 |
| Mani Sharma See Remarks | May 6, 2026 | Award | +1 | $186.28 | $186 | 31,155 |
| Mani Sharma See Remarks | Apr 7, 2026 | Award | +1 | $196.03 | $196 | 31,154 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of AstraZeneca's stock actually held short. Settlement fails (shares not delivered on time) peaked at 185,230 shares on Aug 31, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Aradhana Sarin Officer | Nov 12, 2025 | 15,000 | $1.33M | Nov 12, 2025 | Restricted stock vesting under a registered plan |
| Aradhana Sarin Officer | Nov 13, 2023 | 52,181 | $3.62M | Nov 22, 2022 | 50,806 securities to be sold were obtained at completion of the merger between Alexion Pharmaceuticals, Inc and AstraZeneca PLC under the related Form F-4 registration statement |
Congress trades
29 trades in AstraZeneca reported by 14 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Gilbert Cisneros CA31 | Bought | Dec 18, 2025 | $1K–15K | Jan 12, 2026 |
| Julia Letlow LA05 | Bought | Dec 8, 2025 | $1K–15K | Jan 13, 2026 |
| Gilbert Cisneros CA31 | Bought | Nov 19, 2025 | $1K–15K | Dec 15, 2025 |
| Lisa McClain MI09 · spouse | Sold | Oct 31, 2025 | $1K–15K | Nov 21, 2025 |
| Lisa McClain MI09 · spouse | Sold | Oct 30, 2025 | $1K–15K | Nov 21, 2025 |
| Lisa McClain MI09 · spouse | Bought | Oct 30, 2025 | $1K–15K | Nov 21, 2025 |
| Gilbert Cisneros CA31 | Bought | Oct 21, 2025 | $1K–15K | Nov 18, 2025 |
| Valerie Hoyle OR04 · spouse | Sold | Sep 23, 2025 | $1K–15K | Oct 10, 2025 |
| Lisa McClain MI09 · spouse | Bought | Jul 22, 2025 | $1K–15K | Aug 13, 2025 |
| Lisa McClain MI09 · spouse | Sold (part) | Jun 17, 2025 | $1K–15K | Aug 13, 2025 57 days late |
| Lisa McClain MI09 · spouse | Bought | Jun 9, 2025 | $1K–15K | Aug 13, 2025 65 days late |
| Bruce Westerman AR04 | Sold | Apr 21, 2025 | $1K–15K | May 12, 2025 |
| Bruce Westerman AR04 | Bought | Mar 3, 2025 | $1K–15K | Apr 16, 2025 |
| Valerie Hoyle OR04 · spouse | Bought | Oct 29, 2024 | $1K–15K | Sep 12, 2025 318 days late |
| Daniel Goldman NY10 | Sold | Jul 10, 2023 | $100K–250K | Aug 13, 2023 |
| John Rutherford FL05 | Sold | Jan 15, 2020 | $1K–15K | Jan 23, 2020 |
| Mikie Sherrill NJ11 | Sold | May 28, 2019 | $1K–15K | Jul 8, 2019 |
| Mikie Sherrill NJ11 | Sold | May 28, 2019 | $1K–15K | Jul 8, 2019 |
| Mikie Sherrill NJ11 | Sold | May 28, 2019 | $1K–15K | Jul 8, 2019 |
| Nicholas Van Taylor TX03 · spouse | Sold | Jan 14, 2019 | $1K–15K | Feb 15, 2019 |
| Nicholas Van Taylor TX03 · spouse | Sold | Jan 7, 2019 | $1K–15K | Feb 15, 2019 |
| Earl Blumenauer OR03 | Bought | Mar 7, 2018 | $1K–15K | Apr 5, 2018 |
| John Rutherford FL05 | Bought | Jul 11, 2017 | $1K–15K | Aug 20, 2018 405 days late |
| Dwight Evans PA03 | Bought | Dec 30, 2016 | $1K–15K | May 24, 2017 145 days late |
| Thomas MacArthur NJ03 · joint account | Sold | Dec 2, 2016 | $15K–50K | Jan 7, 2017 |
| Thomas MacArthur NJ03 · joint account | Sold | Aug 12, 2016 | $15K–50K | Sep 10, 2016 |
| Thomas MacArthur NJ03 · joint account | Bought | Feb 22, 2016 | $50K–100K | Mar 3, 2016 |
| K. Michael Conaway TX11 | Sold | May 7, 2014 | $1K–15K | Aug 18, 2014 103 days late |
| Michael K. Simpson ID02 | Sold | Apr 25, 2014 | $1K–15K | May 3, 2014 |
See a number that looks wrong?